Literature DB >> 21325671

Molecular mechanisms affecting fibrin structure and stability.

Susan T Lord1.   

Abstract

Fibrin structure and stability have been linked to many thrombotic diseases, including venous thromboembolism. Analysis of the molecular mechanisms that affect fibrin structure and stability became possible when the crystal structure of fibrinogen was solved. Biochemical studies of natural and recombinant variant fibrinogens have examined the interactions that mediate the conversion of soluble fibrinogen to the insoluble fibrin network. These studies identified intermolecular interactions that control fibrin structure, although some critical events remain ambiguous. Studies show that fibrin structure modulates the enzymatic lysis of the fibrin network, so the molecular mechanisms that control structure also control stability. Studies show that the mechanical stability of the fibrin clot depends on the properties of the fibrin monomer, leading investigators to explore the molecular basis of the monomer's mechanical properties. The work summarized here provides insights that might allow the development of pharmaceuticals and treatments to modulate fibrin structure and stability in vivo and thereby prevent or limit thrombotic disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21325671      PMCID: PMC3070401          DOI: 10.1161/ATVBAHA.110.213389

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  67 in total

1.  The protective effect of the factor XIII Val34Leu mutation on the risk of deep venous thrombosis is dependent on the fibrinogen level.

Authors:  C Y Vossen; F R Rosendaal
Journal:  J Thromb Haemost       Date:  2005-05       Impact factor: 5.824

2.  The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis.

Authors:  Jean-Philippe Collet; Jennifer L Moen; Yuri I Veklich; Oleg V Gorkun; Susan T Lord; Gilles Montalescot; John W Weisel
Journal:  Blood       Date:  2005-08-09       Impact factor: 22.113

3.  Molecular basis of fibrin clot elasticity.

Authors:  Bernard B C Lim; Eric H Lee; Marcos Sotomayor; Klaus Schulten
Journal:  Structure       Date:  2008-02-21       Impact factor: 5.006

4.  Complexity of "A-a" knob-hole fibrin interaction revealed by atomic force spectroscopy.

Authors:  Laurel E Averett; Carri B Geer; Ryan R Fuierer; Boris B Akhremitchev; Oleg V Gorkun; Mark H Schoenfisch
Journal:  Langmuir       Date:  2008-03-20       Impact factor: 3.882

5.  Forced unfolding of coiled-coils in fibrinogen by single-molecule AFM.

Authors:  André E X Brown; Rustem I Litvinov; Dennis E Discher; John W Weisel
Journal:  Biophys J       Date:  2006-12-15       Impact factor: 4.033

6.  Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis.

Authors:  J P Collet; Y Allali; C Lesty; M L Tanguy; J Silvain; A Ankri; B Blanchet; R Dumaine; J Gianetti; L Payot; J W Weisel; G Montalescot
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-08-17       Impact factor: 8.311

7.  Role of fibrinogen levels and factor XIII V34L polymorphism in thrombolytic therapy in stroke patients.

Authors:  Rocio González-Conejero; Israel Fernández-Cadenas; Juan A Iniesta; Joan Marti-Fabregas; Victor Obach; José Alvarez-Sabín; Vicente Vicente; Javier Corral; Joan Montaner
Journal:  Stroke       Date:  2006-07-20       Impact factor: 7.914

Review 8.  The biochemical and physical process of fibrinolysis and effects of clot structure and stability on the lysis rate.

Authors:  J W Weisel; R I Litvinov
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2008-07

9.  Common variation in the C-terminal region of the fibrinogen beta-chain: effects on fibrin structure, fibrinolysis and clot rigidity.

Authors:  Ramzi Ajjan; Bernard C B Lim; Kristina F Standeven; Robert Harrand; Sarah Dolling; Fladia Phoenix; Richard Greaves; Radwa H Abou-Saleh; Simon Connell; D Alastair M Smith; John W Weisel; Peter J Grant; Robert A S Ariëns
Journal:  Blood       Date:  2007-10-09       Impact factor: 22.113

10.  Fibrinogen plasma levels modify the association between the factor XIII Val34Leu variant and risk of coronary artery disease: the EPIC-Norfolk prospective population study.

Authors:  S M Boekholdt; M S Sandhu; N J Wareham; R Luben; P H Reitsma; K-T Khaw
Journal:  J Thromb Haemost       Date:  2006-08-01       Impact factor: 5.824

View more
  53 in total

1.  Engineering fibrin polymers through engagement of alternative polymerization mechanisms.

Authors:  Sarah E Stabenfeldt; Merek Gourley; Laxminarayanan Krishnan; James B Hoying; Thomas H Barker
Journal:  Biomaterials       Date:  2011-10-21       Impact factor: 12.479

Review 2.  Newly-Recognized Roles of Factor XIII in Thrombosis.

Authors:  James R Byrnes; Alisa S Wolberg
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

Review 3.  Fibrinogen and red blood cells in venous thrombosis.

Authors:  Maria M Aleman; Bethany L Walton; James R Byrnes; Alisa S Wolberg
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

Review 4.  Remodeling and Repair in Rhinosinusitis.

Authors:  Jean-Baptiste Watelet; Jean-Michel Dogne; François Mullier
Journal:  Curr Allergy Asthma Rep       Date:  2015-06       Impact factor: 4.806

5.  Lytic resistance of fibrin containing red blood cells.

Authors:  Nikolett Wohner; Péter Sótonyi; Raymund Machovich; László Szabó; Kiril Tenekedjiev; Marta M C G Silva; Colin Longstaff; Krasimir Kolev
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-07-07       Impact factor: 8.311

6.  Fast two-dimensional bubble analysis of biopolymer filamentous networks pore size from confocal microscopy thin data stacks.

Authors:  Matteo Molteni; Davide Magatti; Barbara Cardinali; Mattia Rocco; Fabio Ferri
Journal:  Biophys J       Date:  2013-03-05       Impact factor: 4.033

Review 7.  Fibrin-based biomaterials: modulation of macroscopic properties through rational design at the molecular level.

Authors:  Ashley C Brown; Thomas H Barker
Journal:  Acta Biomater       Date:  2013-09-19       Impact factor: 8.947

8.  Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency.

Authors:  M Zucker; U Seligsohn; O Salomon; A S Wolberg
Journal:  J Thromb Haemost       Date:  2014-06-19       Impact factor: 5.824

9.  Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking.

Authors:  James R Byrnes; Cédric Duval; Yiming Wang; Caroline E Hansen; Byungwook Ahn; Micah J Mooberry; Martha A Clark; Jill M Johnsen; Susan T Lord; Wilbur A Lam; Joost C M Meijers; Heyu Ni; Robert A S Ariëns; Alisa S Wolberg
Journal:  Blood       Date:  2015-08-31       Impact factor: 22.113

10.  Fibrin-loaded porous poly(ethylene glycol) hydrogels as scaffold materials for vascularized tissue formation.

Authors:  Bin Jiang; Thomas M Waller; Jeffery C Larson; Alyssa A Appel; Eric M Brey
Journal:  Tissue Eng Part A       Date:  2012-09-24       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.